, Volume 6, Issue 6, pp 579-581

Primary clinical study on treatment with velcade for multiple myeloma

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Objective

To explore the outcome and side-effects in patients with multiple myeloma treated with velcade and combined chemotherapy.

Methods

6 patients with multiple myeloma were treated with the combination of velcade and dexamethasone or DVD (V-DVD regimen) chemotherapy.

Results

6 patients responded to treatment. 4 patients achieved complete remission (CR), 1 achieved partial remission (PR) and 1 achieved micro responded (MR). Major toxicities consisted of peripheral neuropathy, thrombocytopenia and hepatic impairment.

Conclusion

Velcade combined chemotherapy is an effective and safety treatment for patients with multiple myeloma.